Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
06/06/202406:15GlobeNewswire Inc.O-I GLASS TRANSFORMS PROCESSING OF RECYCLED GLASS WITH INNOVATIVE MOBILE SYSTEMNYSE:OIOI Glass Inc
06/06/202406:15Business WireHoward Energy Partners Announces Launch of $500 Million Offering of Senior Notes
06/06/202406:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
06/06/202406:14GlobeNewswire Inc.Avis rectificatif de l'avis de réunion valant avis de convocation à l'Assemblée Générale du 25 juin 2024LSE:0MUWViktoria Invest Sa
06/06/202406:12Alliance NewsAlliance NewsShares in N Brown soar as sees improved product revenue performanceLSE:BWNGBrown (n) Group Plc
06/06/202406:12GlobeNewswire Inc.Netcompany - Transactions in connection with share buyback programmeTG:60NNetcompany Group AS
06/06/202406:12PR Newswire (US)Summit Midstream Partners, LP Announces Expiration and Results for Asset Sale Offer to Purchase up to $215,000,000 Aggregate Principal Amount of Outstanding 8.500% Senior Secured Second Lien Notes Due 2026NYSE:SMLPSummit Midstream Partners LP
06/06/202406:11PR Newswire (US)Talroo Releases AI SmartScreen Feature to Better Connect Qualified Candidates and Employers as Gap in Job Applicant Qualifications Hits 15-Year High
06/06/202406:10CointelegraphRobinhood to buy Bitstamp crypto exchange to enable institutional trading in USCOIN:BTCUSDBitcoin
06/06/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GIIIG III Apparel Group Ltd
06/06/202406:10PR Newswire (US)Top Tier K9 Recognized as World's Greatest Dog Training Company
06/06/202406:08GlobeNewswire Inc.Virbac : Declaration of the number of shares and voting rights 05/2024EU:VIRPVirbac SA
06/06/202406:08GlobeNewswire Inc.Virbac : Déclaration d'actions et de droits de vote 05/2024EU:VIRPVirbac SA
06/06/202406:08Alliance NewsAlliance NewsCOMMODITIES MARKET: Oil prices climb; gold advances as dollar falls
06/06/202406:07PR Newswire (US)Zenyth Partners Announces Investment in LifeCare Home Health Family
06/06/202406:05GlobeNewswire Inc.Xtract One Technologies Secures Contracts with NBA, MLB & NHL Teams Following New U.S. DHS SAFETY Act DesignationTSX:XTRAXtract One Technologies Inc
06/06/202406:05Business WireUnbabel Releases TowerLLM, the First Generative AI Model to Outperform GPT-4o, GPT-3.5 and Lead the Market in Machine Translation
06/06/202406:05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantNASDAQ:RNACCartesian Therapeutics Inc
06/06/202406:05Business WireG-III Announces Strategic Partnership with AWWGNASDAQ:GIIIG III Apparel Group Ltd
06/06/202406:04PR Newswire (US)Keystone Policy Center Honors Anterix President & CEO Rob SchwartzNASDAQ:ATEXAnterix Inc
06/06/202406:03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AEYEAudioEye Inc
06/06/202406:03PR Newswire (US)Quality Heating, Cooling, Plumbing & Electric Celebrates 10 Years of Helping Tulsa-Area Residents
06/06/202406:03PR Newswire (US)Tigermed Advances Clinical Data Management with Veeva Vault EDCNYSE:VEEVVeeva Systems Inc
06/06/202406:02PR Newswire (US)RADCOM Secures Over $45M in New Contracts Since the Beginning of 2024NASDAQ:RDCMRadcom Ltd
06/06/202406:00GlobeNewswire Inc.The Chicago School Announces Bill Brown, Psy.D. as Provost
06/06/202406:00GlobeNewswire Inc.B2Gold and Sandbox Royalties Partner to Create Versamet Royalties; B2Gold Receives $90 Million Equity Interest in VersametAMEX:BTGB2Gold Corp
06/06/202406:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:BTDRBitdeer Technologies Group
06/06/202406:00Alliance NewsAlliance NewsLONDON MARKET MIDDAY: Europe gets boost ahead of ECB rate call
06/06/202406:00GlobeNewswire Inc.IAE AG and FTAI Aviation Sign Strategic V2500® Engine Maintenance Services AgreementNYSE:RTXRTX Corporation
06/06/202406:00GlobeNewswire Inc.Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed MelanomaNASDAQ:REPLReplimune Group Inc